Product NDC: | 0703-0045 |
Proprietary Name: | Methylprednisolone |
Non Proprietary Name: | Methylprednisolone acetate |
Active Ingredient(s): | 40 mg/mL & nbsp; Methylprednisolone acetate |
Administration Route(s): | INTRAMUSCULAR |
Dosage Form(s): | INJECTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0703-0045 |
Labeler Name: | Teva Parenteral Medicines, Inc |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA040620 |
Marketing Category: | ANDA |
Start Marketing Date: | 20061031 |
Package NDC: | 0703-0045-01 |
Package Description: | 1 VIAL, MULTI-DOSE in 1 CARTON (0703-0045-01) > 10 mL in 1 VIAL, MULTI-DOSE |
NDC Code | 0703-0045-01 |
Proprietary Name | Methylprednisolone |
Package Description | 1 VIAL, MULTI-DOSE in 1 CARTON (0703-0045-01) > 10 mL in 1 VIAL, MULTI-DOSE |
Product NDC | 0703-0045 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Methylprednisolone acetate |
Dosage Form Name | INJECTION |
Route Name | INTRAMUSCULAR |
Start Marketing Date | 20061031 |
Marketing Category Name | ANDA |
Labeler Name | Teva Parenteral Medicines, Inc |
Substance Name | METHYLPREDNISOLONE ACETATE |
Strength Number | 40 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] |